Pharmaceutical Industry Analysis and Statistics (since 2008) on Reportlinker

A brief recession and the devaluation of the local currency have demonstrated that Belarus has not beenable to escape the global economic crisis, although sheer lack of integration into the global financialsystem has done much to blunt its impact. According to BMI, the country?s pharmaceutical secto ...

Industries : Healthcare, Pharmaceutical

Lebanon Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

We expect total drug spending in Lebanon to increase from under US$500mn in 2008 to US$605mn in2013, a compound annual growth rate (CAGR) of 3.9% in US dollar terms, with 1.75% of GDP dedicatedto pharmaceutical expenditure by 2013.The Minister of Health, Mohammad Jawad Khalifeh, has held the positio ...

Industries : Healthcare, Pharmaceutical

Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine

$ 11 400
October 2009

IntroductionCRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there are 77 agents in development for CRC, 4 of which are in late-phase ...

Industries : Therapy

Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes

$ 5 700
October 2009

IntroductionThe author expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest growth is expected in the non-insulin market, the insulin ma ...

Industries : Drug and Medication

Antidiabetics in Australia Market Forecast

$ 5 700
October 2009

Industries : Drug and Medication

Company Financials: Nestlé S.A.

$ 75
October 2009

IntroductionThe Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. THIS PRODUCT HAS B ...

Industries : Beverage, Pharmaceutical

Pharmaceutical & Medicine Manufacturing in the US - Industry Risk Rating Report

$ 803
October 2009

INDUSTRY RISK RATINGS REPORTThis is the replacement for May 2009 edition of Pharmaceutical & Medicine Manufacturing in the US Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pharmaceutical & Medicine Manu ...

Industries : Pharmaceutical

Pharmaceutical Product Manufacturing in Australia - Industry Risk Rating Report

$ 788
October 2009

INDUSTRY RISK RATINGS REPORTThis is the replacement for June 2009 edition of Pharmaceutical Product Manufacturing in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pharmaceutical Product Manufa ...

Industries : Pharmaceutical

Pharmaceuticals Wholesaling in Australia - Industry Risk Rating Report

$ 788
October 2009

INDUSTRY RISK RATINGS REPORTThis is the replacement for March 2009 edition of Pharmaceuticals Wholesaling in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pharmaceuticals Wholesaling in Austra ...

Industries : Pharmaceutical, Wholesaling

Pharmacies in Australia - Industry Risk Rating Report

$ 788
October 2009

INDUSTRY RISK RATINGS REPORTThis is the replacement for June 2009 edition of Pharmacies in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pharmacies in Australia industry. Industry Risk is assu ...

Industries : Pharmaceutical, Pharmacies and Drug Stores

Cosmetic and Toiletry Retailing in Australia - Industry Risk Rating Report

$ 788
October 2009

INDUSTRY RISK RATINGS REPORTThis is the replacement for July 2009 edition of Cosmetic and Toiletry Retailing in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Cosmetic and Toiletry Retailing in ...

Industries : Pharmacies and Personal Care Stores, Pharmacies and Drug Stores

Contract Packing Services in Australia - Industry Risk Rating Report

$ 788
October 2009

INDUSTRY RISK RATINGS REPORTThis is the replacement for July 2009 edition of Contract Packing Services in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Contract Packing Services in Australia i ...

Industries : Pharmaceutical, Chemical

Pathology Services in Australia - Industry Risk Rating Report

$ 788
October 2009

INDUSTRY RISK RATINGS REPORTThis is the replacement for July 2009 edition of Pathology Services in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Pathology Services in Australia industry. Indus ...

Industries : Pathology

China Pharmaceutical Chain Industry Report, 2009

$ 1 600
October 2009

According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 billion (30.35%) than RMB43.91 billion in 2007. In 2008, the average profit margin of top 100 enterp ...

Industries : Pharmaceutical

Bahrain Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

From BHD44mn (US$114mn) in 2008, BMI forecasts that Bahrain?s pharmaceutical market will expandto be worth BHD61mn (US$160mn) in 2018. While the market will remain small in absolute terms, rapidvalue growth, representing a compound annual growth rate (CAGR) of 6.8% and a favourable politicaleconomic ...

Industries : Healthcare, Pharmaceutical

China Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

In BMI?s view, China is arguably the most attractive emerging pharmaceutical market. Though to 2013,we are forecasting a compound annual growth rate (CAGR) of 15.45%. Annual per-capita spending willrise from US$27.60 to US$54.40. Spending as a percent of GDP is expected to increase from 0.97% to1.16 ...

Industries : Healthcare, Pharmaceutical

Portugal Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

BMI calculates that pharmaceutical sales in Portugal reached EUR3.61bn (US$5.31bn) in 2008. Wecalculate that the sales of prescription and over-the-counter (OTC) medicines will reach a value ofEUR0.302bn by 2013, equating to a constant annual growth rate (CAGR) of 2.79% in local currencyterms. We no ...

Industries : Healthcare, Pharmaceutical

GlaxoSmithKline plc: PharmaVitae Profile

$ 5 700
October 2009

IntroductionThis analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An inte ...

Industries : Pharmaceutical

Lithuania Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

BMI calculates that Lithuania?s pharmaceutical market reached a value of LTL1.70bn (US$0.70bn) in2008. By 2013, we expect the value of the prescription and over-the-counter (OTC) markets to reach avalue of LTL2.13bn, equating to a compound annual growth rate (CAGR) of 4.61% over the forecastperiod. ...

Industries : Healthcare, Pharmaceutical

South Africa Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

We expect the value of the total pharmaceutical market to increase from US$2.5bn in 2008 to US$4.2bnby 2013, representing a compound annual growth rate (CAGR) of 10.8% in US dollar terms and 8.6% inlocal currency. Per-capita spending on medicines will reach 81.6% by this time while only 0.89% of GDP ...

Industries : Healthcare, Pharmaceutical

Venezuela Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

BMI calculates that pharmaceutical sales in Venezuela reached VEB7.5bn (US$3.57bn) in 2008. By2013, we forecast the Venezuelan pharmaceutical market will be worth VEB26.0bn, increasing at acompound annual growth rate (CAGR) of 28.23%. BMI notes that as a result of the weakeningVenezuelan bolivar, d ...

Industries : Healthcare, Pharmaceutical

Generics: Global Industry Guide

$ 1 495
October 2009

The Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the Generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive ...

Industries : Generic Drug

Snapshots Australia Pharmaceuticals 2009

$ 600
October 2009

Snapdata's Snapshots Australia Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Australian pharmaceutical market and covers Ethical and OTC drugs. Market value ...

Industries : Pharmaceutical

Snapshots Bulgaria Pharmaceuticals 2009

$ 600
October 2009

Snapdata's Snapshots Bulgaria Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Bulgarian pharmaceutical market and covers prescription and OTC pharmaceuticals. ...

Industries : Pharmaceutical

Snapshots France Pharmaceuticals 2009

$ 600
October 2009

Snapdata's Snapshots France Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the French pharmaceutical market and covers refundable, non-refundable and hospital us ...

Industries : Pharmaceutical

Mexico Real Estate Report Q4 2009

$ 495
October 2009

BMI calculates that pharmaceutical sales in Peru reached PEN2.58bn (US$0.88bn) in 2008. Thisrepresents impressive growth of 8.5% in local currency terms between 2007 and 2008. However, BMI?sforecast for 2009 is more conservative and we calculate that the drug market will experience growth of5.4%, re ...

Industries : Healthcare, Pharmaceutical

Russia Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

This quarter BMI introduces 10-year forecasts for the Russian pharmaceutical markets, providing anopportunity to look beyond the current financial crisis and assess the growth potential for the largest andmost populous pharmaceutical market in Central and Eastern European (CEE). By 2018, we forecast ...

Industries : Healthcare, Pharmaceutical

Spain Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

In BMI?s Business Environment Ratings for Q409, Spain remains placed fourth out of the nine WesternEuropean Markets surveyed. Spain?s large and generously subsidised drug market, low genericpenetration, ageing population and stable economic and political system mean that it scores highlycompared wit ...

Industries : Healthcare, Pharmaceutical

United Kingdom Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

In BMI?s Business Environment Ratings (BER) for Q409, the UK improved its position by one place,and is now ranked 5th of the 9 Western European markets surveyed. However, while the UK is one of themost developed pharmaceutical markets in the world, pressing economic and political issues ? as well as ...

Industries : Healthcare, Pharmaceutical

United States Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

Despite a downturn in growth rates in the US pharmaceuticals & healthcare markets, the country remainsa core component for any company looking to achieve global success. Healthcare spending in 2008reached US$2.3trn, while sales of pharmaceuticals topped US$309bn.For BMI?s US Pharmaceuticals & Health ...

Industries : Healthcare, Pharmaceutical

<<
< Previous
1
2
3
4
5
6
7
8
9
10
100
Next >
>>

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.